Search Results

Enrolled in Phase 1/2 “ELUCIDATE” Trial Assessing GTAEXS617 in Advanced Solid Tumours A Conversation with Murat Tunaboylu, Antiverse Co-Founder and CEO GPCR Events, Meetings, and Webinars ONCORNET2.0 Final Symposium

Deep mutational scanning (DMS) is a powerful method for studying the functional consequences of various DMS can be used to comprehensively assess the functional impact of mutations in a candidate protein, Deep mutational scanning: assessing protein function on a massive scale. Measuring the activity of protein variants on a large scale using deep mutational scanning. Predicting Drug Resistance Using Deep Mutational Scanning.

October 2022 Mechanism of enhanced sensitivity of mutated β-adrenergic-like octopamine receptor to amitraz However, the underlying molecular mechanism of the enhanced sensitivity or toxicity of amitraz to mutated

GPCR Podcast Strategic Partners Murat Tunaboylu & Ben Holland About Murat Tunaboylu "Murat Tunaboylu, After switching to biotech, Murat has built cell imaging software and lab robots to accelerate cancer Murat Tunaboylu on the web Antiverse DSV Future of Drug Discovery Podcast Twist Bioscience LinkedIn Twitter

Murat Tunaboylu, CEO Antiverse Before engaging Yamina, our team faced hurdles in navigating complex early

. - Murat Tunabolyu, CEO Antiverse Frequently Asked Questions 01 What size companies do you work with